Active BE 0774.905.878Private limited company

Bioversa International

· 4 yrs active

Conclusion Checked

The computed 12-month bankruptcy probability of Bioversa International is 7.7% (elevated). The 2023 annual accounts show negative equity (€-809). The company has been active since 2021 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).

Based on the State Gazette, CBE and 2 annual accounts.

Key figures

Equity	€-809
Active	4 yrs
Board	1
Locations	1

Financial profile 3 of 5 axes measured · computed by Checked

80 / 100

This figure rests on 3 of 5 axes. Too few to say where this company is strong or weak.

Computed on 3 of 5 axes. Not measured: health, profitability. An unmeasured axis is not a zero: no data was read for it.

Health -

Profitability -

Solvency 100

Growth 55

Stability 86

Bankruptcy probability (12 mo) Checked model v1 · free

7.7% Elevated

0%0,5%1,5%4%10%≥25%

Recent warning signals +Young company +No NACE activity registered +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based

3 / 100

Low risk

Components

· 1 administrative flag (+3)

Trust signals 1 signals

No legal incidents

No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags1 events

Address struck

Health barometer

No health score: the filing is too brief

The accounts filed for FY 2023 supply 2 of the 6 factors this model weighs. Below 3 we publish no score, because it would mostly describe the model rather than this company.

This is not a judgement about the company. Micro and abbreviated schemas may omit turnover (rubriek 70), which makes the EBITDA margin and often the interest coverage impossible to compute.

Financial overview2 NBB filings

Annual accounts filed on 26-08-2024 with the NBB · fiscal year 2023 · micro

Operating resultNet result

EBITDA

€-1k

- 22-23

Net profit

€-4k

- 22-23

Cash flow

€-1k

- 22-23

Equity

€-809

0.0% 22-23

Debt

€809

0.0% 22-23

Debt ≤ 1y

€809

0.0% 22-23

Debt / equity

-1.00

0.0% 22-23

ROE

470.8%

- 22-23

Figures by fiscal year

Highlight YoY changes (±10%)

Fiscal year	2023
Deposit	micro
Revenue	-
EBITDA	-
Net profit	-
Cash flow	-
Staff costs	-
Income taxes	-
Dividends	-
Total assets	-
Equity	€-809
Debt	€809
of which ≤ 1y	€809
of which > 1y	-
Working capital	-
Employees (FTE)	-

Ratios (computed)

	2023
Current ratio	-
Quick ratio	-
Working capital ratio	-
Solvency	-
Debt / equity	-1.00
Long-term debt ratio	-
Interest coverage	-
Gross margin	-
Net margin	-
ROA	-
ROE	-
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Full annual accounts (5 line items)

Filed balance sheet and income statement, exactly as deposited with the NBB.

Line item	Code	2023
Balance sheet, Equity & liabilities
Equity	10/15	€-809
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€-4k
Amounts payable	17/49	€809
Amounts payable within one year	42/48	€809

This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan. See plans →

Ratios computed by Checked.

Directors & mandates 1 directors

Current directors & mandates

Abderrahmane Boussaklatan
Director
State Gazette act 24147607 (14-10-2024)

Current
14-10-2024 → present
2 events
- 14-10-2024 Resigned· Director
- 14-10-2024 Appointed· Director

Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.

Legal Structure

NACE primary	-
Legal form	Private limited company(610)
Incorporation	01-10-2021
Status	Active
Postal code	-

Establishment units 1 location

Emile Feronstraat 103, 1060 Sint-Gillis (bij-Brussel)

Handelsbemiddeling in de niet-gespecialiseerde groothandel

since 20242.366.216.812

Physical sites registered in the Crossroads Bank for Enterprises (CBE).

Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
21616G0030/00T016	Brussels	342 m²	1 · 99 m²	13.8 m · 3 fl.
21562A0337/00T002	Brussels	63 m²	1 · 63 m²	12.2 m · 3 fl.

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Updates 6 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025

10-06-2025

KBO administration Address struck

Kersbeeklaan 308 Die Sitzadresse Avenue Kersbeek / Kersbee- 1180 Uccle · event 02-04-2025

2024

14-10-2024

State Gazette act Capital & shares

26-08-2024

NBB filing Annual accounts filed

fiscal year 2023 · micro

2023

01-12-2023

State Gazette act Capital & shares

30-11-2023

NBB filing Annual accounts filed

fiscal year 2022 · micro

Lifecycle & Insolvency Signals1 events

10-06-2025

KBO administration Address struck

Date: 02-04-2025 · Kersbeeklaan 308 Die Sitzadresse Avenue Kersbeek / Kersbee- 1180 Uccle · Publications in State Gazette ↗

Time machine, BS events + macro context 2021, 2026

Macro context

2020-Q2/Q3 COVID lockdown

2022 energy crisis

2023-2024 ECB rate hikes

Legend

Bankruptcy

Interim / reorg

KBO event

Belgian State Gazette reading coverage 0 of 4 acts read

We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 2 acts

Capital history · 2

14-10-2024

Capital change

01-12-2023

Capital change

All acts · 2 updated 1 year ago

2024

14-10-2024 Transaction in capital or shares Capital & shares

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Abderrahmane Boussaklatan",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Abderrahmane Boussaklatan",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": null,
          "contribution_amount_eur": null
        }
      ],
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2024-10-04",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2024-10-04",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2024-10-04"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0774.905.878",
    "name_full": "Bioversa International",
    "legal_form": "SRL",
    "_kbo_filled_from_list": true,
    "is_foreign_registered": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Marion de Crombrugghe",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire"
  },
  "co_filed_documents": [],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "Abderrahmane Boussaklatan",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

2023

01-12-2023 All shares are now held by a single shareholder Capital & shares

Original publication ↗

Technical details

{
  "events": [
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "person",
          "name": "Arnaud Trejbiez",
          "share_class": null,
          "liberation_pct": null,
          "contribution_kind": null,
          "n_shares_subscribed": 1000,
          "contribution_amount_eur": null
        }
      ],
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "eenhoofdigheid_declaration",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2023-11-23",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2023-11-23",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2023-11-21"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0774.905.878",
    "name_full": "Bioversa International",
    "legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Serge Solau",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire"
  },
  "co_filed_documents": [],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "person",
      "name": "Arnaud Trejbiez",
      "role": "aandeelhouder",
      "n_shares": 1000,
      "share_class": null
    },
    {
      "kbo": "0479.092.007",
      "pct": null,
      "kind": "org",
      "name": "Kreanove",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": null
    }
  ],
  "share_classes_after": []
}

Credit advice verdict per customer and amount

Company registry (CBE) Crossroads Bank

Names & trade names

Legal nameFR

Bioversa International

Registration history

02-04-2025 Address struck

Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.